2009
DOI: 10.1002/humu.20853
|View full text |Cite
|
Sign up to set email alerts
|

Hereditary pancreatitis caused by mutation-induced misfolding of human cationic trypsinogen: A novel disease mechanism

Abstract: We investigated the biochemical properties and cellular expression of the c.346C>T (p.R116C) human cationic trypsinogen (PRSS1) mutant, which we identified in a German family with autosomal dominant hereditary pancreatitis. This mutation leads to an unpaired Cys residue with the potential to interfere with protein folding via incorrect disulfide bond formation. Recombinantly expressed p.R116C trypsinogen exhibited a tendency for misfolding in vitro. Biochemical analysis of the correctly folded, purified p.R116… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

6
114
0
1

Year Published

2010
2010
2017
2017

Publication Types

Select...
7
3

Relationship

2
8

Authors

Journals

citations
Cited by 139 publications
(121 citation statements)
references
References 40 publications
6
114
0
1
Order By: Relevance
“…CPA1 had no detectable effect on trypsinogen activation, trypsin activity or trypsinogen degradation by CTRC, indicating that CPA1 variants do not exert their effect via increasing the intrapancreatic trypsin activity. On the other hand, most of the loss-of-function CPA1 variants exhibit markedly reduced secretion, raising the possibility that CPA1 variants undergo misfolding in the ER and cause ER stress, as demonstrated previously for some PRSS1 and CTRC mutants (Kereszturi et al 2009b;Beer et al 2013). Indeed, the expression of p.N256K variant in AR42J rat pancreatic acinar cells resulted in ER stress, as evidenced by increased splicing of X-box binding protein 1 and elevated mRNA levels of the chaperons BiP and calreticulin.…”
Section: Cpa1 Variantsmentioning
confidence: 68%
“…CPA1 had no detectable effect on trypsinogen activation, trypsin activity or trypsinogen degradation by CTRC, indicating that CPA1 variants do not exert their effect via increasing the intrapancreatic trypsin activity. On the other hand, most of the loss-of-function CPA1 variants exhibit markedly reduced secretion, raising the possibility that CPA1 variants undergo misfolding in the ER and cause ER stress, as demonstrated previously for some PRSS1 and CTRC mutants (Kereszturi et al 2009b;Beer et al 2013). Indeed, the expression of p.N256K variant in AR42J rat pancreatic acinar cells resulted in ER stress, as evidenced by increased splicing of X-box binding protein 1 and elevated mRNA levels of the chaperons BiP and calreticulin.…”
Section: Cpa1 Variantsmentioning
confidence: 68%
“…It may further explain successful treatments of idiopathic and autoimmune pancreatitis by bile salts demonstrated in several case reports and small pilot studies in humans (38,46,49). Thus this treatment strategy may become important, even though a recent publication showed a connection between ER stress and hereditary pancreatitis (19).…”
Section: G883mentioning
confidence: 93%
“…A pathogenic role for ER stress is supported by a mutation (p.R116C) that causes misfolding and intracellular retention of human PRSS1, but does not affect its activation (6). This mutation, which causes ER stress, results in chronic pancreatitis.…”
Section: Introductionmentioning
confidence: 99%